ZyVersa Therapeutics (NASDAQ:ZVSA) just reported results for the first quarter of 2024.
- ZyVersa Therapeutics reported earnings per share of -$4.53. This was below the analyst estimate for EPS of -$3.70.
- The company did not report any revenue for the quarter.